Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.34
-0.01 (-0.11%)
May 5, 2026, 12:51 PM EDT - Market open
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
$138,387
Profits / Employee
$22,644
Market Cap
11.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | 21,650 | -316 | -1.44% |
| Mar 31, 2019 | 21,966 | -1,558 | -6.62% |
| Mar 31, 2018 | 23,524 | 853 | 3.76% |
| Mar 31, 2017 | 22,671 | 496 | 2.24% |
| Mar 31, 2016 | 22,175 | 1,802 | 8.85% |
| Mar 31, 2015 | 20,373 | 1,952 | 10.60% |
| Mar 31, 2014 | 18,421 | 1,804 | 10.86% |
| Mar 31, 2013 | 16,617 | 1,417 | 9.32% |
| Mar 31, 2012 | 15,200 | 277 | 1.86% |
| Mar 31, 2011 | 14,923 | 1,468 | 10.91% |
| Mar 31, 2010 | 13,455 | 2,227 | 19.83% |
| Mar 31, 2009 | 11,228 | 1,653 | 17.26% |
| Mar 31, 2008 | 9,575 | 555 | 6.15% |
| Mar 31, 2007 | 9,020 | 1,495 | 19.87% |
| Mar 31, 2006 | 7,525 | 1,390 | 22.66% |
| Mar 31, 2005 | 6,135 | -20 | -0.32% |
| Mar 31, 2004 | 6,155 | 303 | 5.18% |
| Mar 31, 2003 | 5,852 | 409 | 7.51% |
| Mar 31, 2002 | 5,443 | 314 | 6.12% |
| Mar 31, 2001 | 5,129 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
| Lantheus Holdings | 1,193 |
RDY News
- 5 days ago - Canada gives nod for Dr Reddy’s semaglutide - The Times of India
- 5 days ago - Dr. Reddy's Laboratories Secures Health Canada Approval for Generic Semaglutide - GuruFocus
- 6 days ago - Canada Approves Dr. Reddy's Generic Version of Novo Nordisk's Ozempic - WSJ
- 6 days ago - Dr. Reddy's (RDY) Secures Approval for Generic Semaglutide in Canada - GuruFocus
- 6 days ago - Dr. Reddy’s Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada - Financial Post
- 6 days ago - Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada - Business Wire
- 6 days ago - Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug - NDTV
- 6 days ago - OneSource Pharma shares surge over 3% after partner gets approval for Semaglutide injection - Business Upturn